Equity Overview
Price & Market Data
Price: $11.36
Daily Change: -$0.23 / 2.02%
Daily Range: $11.05 - $11.92
Market Cap: $1,648,835,200
Daily Volume: 3,613,407
Performance Metrics
1 Week: 13.60%
1 Month: 26.01%
3 Months: 19.04%
6 Months: -28.64%
1 Year: -72.85%
YTD: -52.50%
Company Details
Employees: 191
Sector: Health technology
Industry: Biotechnology
Country:
Details
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.